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The evidence for specific binding of N-(7-nitrobenz-2-oxa-1,3-diazol-4-y1) -cokemid (NBD-col- 
cemid), a fluorescent analog of colcemid (N-deacetyl-N-methyl-colchicine), to liver alcohol dehydroge- 
nase is presented. Alcohol dehydrogenase bound NBD-colcemid in a time-dependent manner, enhanced 
the fluorescence intensity, and caused a large blue shift of the emission maximum of the free drug. The 
specificity of binding was determined for both the colchicine nucleus and the NBD moiety. The binding 
was not affected by the presence of alcohol or NAD in the reaction mixture. Preincubation of horsc 
liver alcohol dehydrogenase with colcemid inhibited the binding to a considerable extent. NBD-colcemid 
inhibited the enzymic activity of alcohol dehydrogenase in a mixed-type noncompetitive mode with a K, 
value of 32 pM, whereas cokemid showed noncompetitive inhibition with a K, of 100 pM. The associa- 
tion rate constant of NBD-colcemid binding with liver alcohol dehydrogenase was 587 M-' s- '  at 25 "C. 
The stoichiometry and dissociation constant of the binding reaction were 0.62/dimer and 12 pM, respec- 
tively. Donor quenching experiments showed that both tryptophans of alcohol dehydrogenase transferred 
energy to the bound NBD-colcemid. Thus, this study reports the binding of a colchicine analog to a 
protein other than tubulin with high affinity. It is concluded that NBD-colcemid binding to dehydroge- 
Rases is a general phenomenon, but the common structural element(s) that is responsible for the binding 
activity, and which exists among tubulin and dehydrogenases, has yet to be determined. 
Keywords: alcohol dehydrogenase; N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-colcemid; fluorescence; en- 
zymic inhibition; antimitotic drugs. 
Colcemid (N-deacetyl-N-methyl-colchicine), a structural 
analog of colchicine, lacks the carbonyl group at the C7 posi- 
tions of its B-ring. This causes dramatic differences i n  the in- 
teraction of colcemid with tubulin when compared to colchicine. 
For colchicine, the tubulin interaction is slow, has high activa- 
tion energy, and is essentially irreversible, whereas for colcemid, 
the tubulin interaction is relatively fast and reversible, and has 
similar activation energy [I -31. Nevertheless, colcemid also in- 
terferes with microtubule-dependent cell functions and possesses 
therapeutic properties like colchicine 14, 51. 
We are interested in studying the role of the B-rings of col- 
chicine and colcemid in their binding with tubulin. Unfortu- 
nately, the colcemid-tubulin complex is non-fluorescent unlike 
the colchicine-tubulin complex 161. A fluorescent-labeled col- 
cemid, N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) (NBD) - colcemid 
has been synthesized by Hiratsuka and Kato [7], which has a 
favorably high quantum yield in environments of low polarity 
and a very low quantum yield in water [7]. These authors re- 
ported that NBD-colcemid reversibly disrupted the metaphase 
spindles of sea urchin eggs [7]. Their results indicate that the 
NBD-colcemid retains the biological activity of unlabeled col- 
Correspondence to B. Bhattacharyya, Department of Biochemistry, 
Bose Institute, P 1/12, CIT Scheme, VIIM, Calcutta 700 054, India 
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nitrobenz-2-oxa- 1,3-dixm-4-yI. 
Enzynrs. Alcohol dehydrogenase (EC 1.1.1 . I ) ;  isocitrate dehydro- 
genase (EC 1.1.1.42): malate dehydrogenase (EC 1 .I . I  .37); glutamate 
dehydrogenase (EC 1.4.1.3); glyceraldehyde-3-phosphate dehydroge- 
nase (EC 1.2.1.12). 
cemid, fluorescing strongly when bound to tubulin with excita- 
tion and emission maxima at 465 nm and 530 nm, respectively. 
Assembled microtubules werc directly visualized after mixing 
with NBD-colcemid using a tluorescence microscope. It was re- 
ported from this laboratory that NBD-colcemid, like colcemid, 
binds tubulin at the colchicine site and inhibits tubulin self-as- 
sembly [8]. To our surprise, it was observed that NBD-colcemid 
binds liver alcohol dehydrogenase with spectroscopic feature5 
similar to that of the tubulin-NBD-colcemid complex. As colchi- 
cine or its analogs are not known to bind to any other protein 
with high affinity, it would be of interest to investigate the nature 
of binding of a colchicine analog with liver alcohol dehydroge- 
nase. The results of such a study are presented in this paper. 
MATERIALS AND METHODS 
Lyophilised horse liver alcohol dehydrogenase (LADH), por- 
cine heart isocitrate dehydrogenase, porcine heart malate dehy- 
drogenase, bovine liver glutamate dehydrogenase, yeast glycer- 
aldehyde-3-phosphate dehydrogenase, NAD, colchicine, and 
colcemid were from Sigma. 4-(N-Iodo-acetoxyethyI-N-methyl)- 
amino-7-nitrobenz-2-oxa-1,3-diazole and NBD-colcemid were 
purchased from Molecular Probes. All other chemicals used 
were reagent grade and succinimidc was recrystallized from 
water before use. 
The dehydrogenase solutions were dialyzed for 24 h at 4°C 
against 0.1 M potassium phosphate, pH 7.5, and centrifuged at 
5854 g for 15 min at 4°C to remove any precipitable material. 
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The concentration of LADH was calculated using a molar ab- 
sorption coefficient of c,,, = 3.53X104 M-'  cm-' [91. 
Enzyme assay and inhibition study. Enzymic activities 
were determined spectrophotometrically [lo] in a Beckman DU- 
70 spectrophotometer at 25 "C by measuring absorbance at 
340 nm. The activities were determined in 0.1 M glycine/NaOH, 
pH 9.5. Different concentrations of NAD and 6.5 % ethanol were 
added to the reaction mixture. The enzyme previously diluted in 
ice-cold buffer, was added and the kinetics were followed at 
340 nm. The enzyme was diluted so that the changes in absor- 
bance were linear. The rate of the reaction was calculated from 
the absorbance change and the kinetic data were plotted as recip- 
rocal rates against reciprocal NAD concentrations according to 
Lineweaver and Burk [ll]. 
In the case of the inhibition study, the required concentration 
of NBD-colcemid was added to the reaction mixture containing 
NAD and alcohol, the enzyme was added, and the absorbance 
was followed at 340nm. From the Lineweaver-Burk plots, K, 
values were calculated using the appropriate equations [ 121. 
Fluorescence methods. All fluorescence experiments were 
carried out in a Hitachi F-3000 spectrofluorometer at 25°C. The 
excitation and emission wavelengths for NBD-colcemid were at 
465 nm and 530 nm, respectively, with bandpasses of 5 nm each 
unless mentioned otherwise. For the tryptophan residues of 
LADH, the excitation and emission wavelengths were at 295 nm 
and 340 nm, respectively. The rate constant of the LADH-NBD- 
colcemid interaction was measured under pseudo-first-order 
conditions at 25 "C. The binding parameters of the LADH-NBD- 
colcemid interaction were determined according to Klotz [ 131 
and Scatchard 1141. CD spectra were obtained at 20°C in a 
Jasco-600 spectropolarimeter with 1 cm pathlength. 
Donor quenching of tryptophan-NBD-colcemid energy 
transfer. The donor quenching experiment was performed at 
1 pM LADH and 5 pM NBD-colcemid according to the method 
of Bhattacharyya et al. [IS]. The energy-transfer efficiency in 
the presence of the quencher was measured according to the 
equation 
E ,  _ _ _  l + -  F,,. ,  - &"CD 
F:: cAcA 
where F,, , , is the fluorescence of the donor-acceptor complex 
in presence of the quencher and F l  is the fluorescence of the 
acceptor only, which remains unaltered in the presence or ab- 
sence of quencher. E~ and E, are the absorption coefficients of 
the donor and the acceptor, respectively, at the wavelength 
where the fluorescence of the donor is measured. C,, and C, are 
the concentrations of the donor and acceptor in the complex and 
E is the energy-transfer efficiency. An equation can be con- 
structed combining the energy-transfer efficiencies in the pres- 
ence and absence of quencher: 
where -zD,A is the lifetime of the donor in the presence of accep- 
tor but in the absence of quencher. This equation can be re- 
arranged in the form of a Lehrer equation [16]: 
F"/(F" - F) = I$, + I/(f,k,,[Q]). 
A Lehrer-type plot of F"I(F" - F) versus l /Q where F" is the 
fluorescence of the LADH-NBD-colcemid complex in the ab- 
sence of quencher and F is the fluorescence of the complex in 
the presence of the quencher, was constructed to determine the 
proportion of energy transfer from quenchable and non-quencha- 
ble donors. The emission and excitation wavelengths were 
540 nm and 295 nm, respectively. The emission wavelength for 
500 520 540 560 
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Fig. 1. The fluorescence emission spectra of different proteins with 
NBD-colcemid. 5 pM NBD-colcemid was mixed with 5 pM of the fol- 
lowng proteins: (1 )  tubulin; (2) LADH; (3) hexokinase; (4) BSA; ( 5 )  
papain; (6) lysozyme (all in 10 mM potassium phosphate, pH 6.95, con- 
taining 0.5 mM EGTA and 0.25 mM MgCl, at 25 "C). The fluorescence 
spectra were recorded after 5 min incubation at 25°C. The excitation 
wavelength was at 465 nm in all cases and the emission spectrum of 
NBD-colcemid alone is shown in [8]. 
energy transfer measurements was at 540 nm, as NBD-colcemid 
has a large emission at this wavelength and no significant emis- 
sion from direct excitation of tryptophan residues exists at 
540 nm. Recrystallised succinimide had no absorbance at 295, 
340 or 540 nm. The fluorescence values were corrected for the 
inner-filter effect where necessary. The R,, value was calculated 
according to the equation. 
R, = 8.79 X lo-' (Jx'n '&)""A, 
where J is the overlap integral, 31' is the orientation factor, n is 
the refractive index of the medium between donor and acceptor, 
and &, is the quantum yield of the donor in the absence of the 
acceptor. The distances between the tryptophans of LADH and 
NBD-colcemid were calculated by the following equation : 
R = R,,[(l-E)/E]"'. 
All these calculations were performed according to Cantor and 
Schimmel and references therein [17]. 
RESULTS 
Fig. 1 shows the fluorescence emission spectra of NBD-col- 
cemid in the presence of different proteins. It is observed that, 
like tubulin, horse liver alcohol dehydrogenase enhanced the 
NBD-colcemid fluorescence intensity with a large blue shift of 
the emission maximum. The emission maximum of free NBD- 
colcemid shifted 5 nm upon binding to tubulin and the shift was 
even more (9 nm) upon binding to LADH. This indicated the 
interaction of NBD-colcemid with LADH. Pretreatment of 
LADH with colcemid strongly inhibited enhancement of NBD- 
colcemid fluorescence at colcemid concentrations of approxi- 
mately 1 mM (data not shown). The fluorescence of NBD-col- 
cemid decreased sharply when LADH was preincubated with 
increasing concentrations of urea indicating that the integrity of 
the protein tertiary structure was required for binding. The addi- 
tion of LADH to alkyl NBD analogs produced no change in 
the NBD-fluorescence indicating that the high affinity of NBD- 
colcemid to LADH and the enhanced fluorescence is a combined 
function of both the NBD group and the colchicine nucleus. Un- 
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Fig. 2. Circular dichroic spectra of NBD-colcemid in the presence or 
absence of LADH. 7 pM NBD-colcemid was mixed with 50 pM LADH 
at 20°C in 0.1 M potassium phosphate, pH 7.5, containing 0.5 mM 
MgCI,, and the spectra were followed with time. The spectra are as 
follows: NBD-colcemid (-); NBD-colcemid in the presence of 
LADH immediately after mixing (. . . ' .); NBD-colccmid with LADH 
after 20 min (- - -). 
like tubulin, the incubation of colchicine or colcemid with 
LADH did not produce any fluorescence. Based on these results 
reported above, it is likely that both colchicine and colcetnid 
bind to LADH without the promotion of fluorescence. 
The enhancement of NBD fluorescence that occurs upon 
binding to alcohol dehydrogenase suggests the involvement of 
NBD group of NBD-colcemid in the interaction with the protein. 
The involvement of the NBD group in the binding process was 
further confirmed by the circular dichroic spectra of NBD-col- 
cemid in the presence of LADH. As shown in Fig. 2, the CD 
band corresponding to the NBD group of NBD-colcemid (380- 
520 nm) changed significantly upon the addition of LADH and 
the ellipticity further changed with time. 
Many colchicine analogs are well known pharmacological 
agents that are believed to act primarily through their effects 
on tubulin. If colchicine analogs can interact with other cellular 
targets, new mechanisms of action producing desirable pharma- 
cological or undesirable side effects may be revealed. To test 
whether this binding may have any biological significance, we 
tested the effect of NBD-colcemid and colcemid on the enzyme 
activity of LADH. The rates were ineasured with different NAD 
concentrations using ethanol as a substrate in the presence of 
either NBD-colcemid or colcemid. The Lineweaver-Burk plots 
suggested that NBD-colcemid is a mixed-type noncompetitive 
inhibitor with K,  of approximately 32 pM (Fig. 3A), whereas 
colcemid showed noncompetitive inhibition with K, of 100 pM 
(Fig. 3 B). The mode of inhibition was also consistent with the 
observation that the presence of a saturating amount of NAD 
(1 mM) or ethanol (0.2 M) had no effect on NBD-colcemid 
binding to LADH (data not shown). This indicated that the 
NBD-colcemid-binding site was different from the coenzyme 
or substrate-binding site. 
The binding of NBD-colcemid with LADH quenches the 
tryptophan fluorescence of the enzyme. The quenching of the 
tryptophan fluorescence after mixing LADH with NBD-col- 
cemid was followed as a function of time. Quenching increased 
with time attaining saturation at about 2 h (Fig. 4A)  indicating 
that the bound drug was near the tryptophan(s) of LADH. The 
1200f- 
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Fig. 3. Lineweaver-Burk plot of inhibition of LADH enzymic activity 
by NBD-colcemid (A) and colcemid (B). The formation of NADH was 
followed by observing the absorbance a[ 340 nm. The reaction mixtures 
contained 1.43 M ethanol, 10-200 pM NAD and the following: (A) no 
NBD-colcemid (0); 25 pM NBD-colcemid (A); 50 pM NBD colcemid 
(0); (B) no colcemid (0); 100 pM colcemid (A); 180 pM colcemid in 
0.1 M glycine/NaOH, pH 9.5 (0). 
time dependence of binding was also evident from the kinetic 
profile in Fig. 4B.  The kinetics of the association reaction of 
NBD-colcemid with LADH were studied under pseudo-first-or- 
der conditions by monitoring the increase in ligand emission 
intensity as a function of time. The NBD-colcemid data were 
then fitted to a sum of exponentials. A single exponential func- 
tion with a zero-time offset was enough to fit the data satisfacto- 
rily. A typical kinetic profile is shown in Fig. 4B. The associa- 
tion rate constant for the LADH and NBD-colcemid interaction 
was 587 M-' s-I. 
The fluorescence of free NBD-colcemid is enhanced 1 1 -fold 
upon binding to LADH. A titration of NBD-colcemid with 
LADH at 25°C is shown in the inset of Fig. 5. The data were 
analysed by the method of Klotz, yielding a dissociation con- 
stant of 10.4 pM for the NBD-colcemid-LADH interaction. The 
dissociation constant and stoichiometry were also measured by 
Scatchard analysis (Fig. 5 )  and were 12.5 pM and 0.62 mol/rnol 
LADH dimer, respectively. 
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Fig. 4. Tryptophan fluorescence quenching (A) and time-dependent 
binding (B) of NBD-colcemid binding to tubulin. (A) 2 pM LADH 
was mixed with 4 pM NBD-colcemid and the tryptophan fluorescence 
was followed fur 2 h at 336 nm exciting at 295 nm. (B) 1 pM LADH was 
mixed with 25 pM NBD-colcemid at 15°C. The fluorescence intensity at 
530 nm with time was recorded as many times as possible. The excita- 
tion wavelength was at 465 nm. For both A and B, the solution condi- 
tions are as in Fig. 2. 
It is known that LADH contains two tryptophan residues: 
Trpl5 and Trp314. Trpl5 is exposed to the solvent and can be 
quenched by external quenchers whereas Trp314 is buried and 
inaccessible to quenchers [IS]. To obtain information about the 
position of the NBD-colcemid-binding site on LADH, energy 
transfer studies of NBD-colcemid with the tryptophan residues 
of LADH were performed; the absorption spectra of NBD-col- 
cemid overlap well with the emission spectra of tryptophan. As 
only one tryptophan molecule of LADH could be quenched by 
collisional quenchers, the donor quenching of fluorescence en- 
ergy transfer may give an idea about the distance of the NBD- 
colcemid-binding site from the tryptophan residues. In this case, 
succinimide does not quench the acceptor NBD-colcemid (data 
not shown). The inset of Fig. 6 represents the Lehrer plot of 
succinimide quenching of tryptophan fluorescence of LADH in 
the absence of NBD-colcemid. The y-axis intercept of 2.9 indi- 
cates that approximately SO % of the tryptophan molecules could 
be quenched, which is expected from the previously known data, 
and probably indicates that Trpl5 is quenched. Fig. 6 shows a 
Lehrer-type plot of donor quenching of fluorescence energy 
transfer of the LADH-NBD-colcemid complex. In this case, the 
intercept on the y-axis is 1.85 indicating that 45 % of the energy 
transfer occurred from tryptophan that could not be quenched 
by succinimide and the remaining 55% was from the tryptophan 
residue that could be quenched. The estimated energy-transfer 
efficiency value was 1.5 indicating significant energy transfer 
from both the tryptophans. The energy transfer from the quench- 
0 0.2 0.4 0.6 
r 
Fig.5. Scatchard plot of LADH binding to NBD-colcemid. 2 pM 
LADH was titrated with 0.4-20 pM NBD-cokeinid. Inset, titration of 
NBD-colcemid with LADH. 0.5 pM NBD colceniid was titrated with 
1 - 10 pM LADH. The excitation and emission wavelengths were at 
500 nm and 530 nm, respectively. The solution conditions are the same 
as in Fig. 2. 
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Fig. 6. Lehrer plot of succinimide quenching of LADH tryptophan 
fluorescence during energy transfer with NBD-colcemid. I pM 
LADH was complexed with 5 pM NBD-colcemid and the complex was 
titrated with succinimide (0.017-0.5 M). The emission wavelength was 
at 540 nni and after each addition of succinimide, the excitation intensity 
was recorded at 295 nm. Inset, Lehrer plot of succinimide quenching of 
tryptophan fluorescence of LADH. 1 pM LADH was titrated with 
0.017-0.5 M succinimide. The emission wavelength was at 340 nm and 
after each addition uf succinimide, the excitation intensity was recorded 
at 295 nm. The solution conditions were the same us in Fig. 2. 
able tryptophan is therefore 1.5XOS5, i.e. 0.825. This suggests 
a distance of 2.3 -3.0 nm between NBD-colcemid and the 
quenchable Trpl5. Similarly, the estimated distances from 
Trp314 may be approximately 2.6-3.5 nm. These estimates are 
significantly shorter than the NADH-TrplS distances, which are 
3.6 nm and 5.2 nm, and significantly longer than the NADH- 
Trp314 distances, which are 1.7 nm and 2.4 nm (from X-ray 
crystal structure data of the NADH-dimethyl sulphoxide-LADH 
ternary complex ; [ I  41) supporting the idea of a binding site dis- 
tinct from the coenzyme-binding site. 
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Table 1. The enhancement of NBD-colcemid fluorescence in the pres- 
ence of different dehydrogenases. 5 pM NBD-colcemid was mixed 
with 5 pM of the different dehydrogenases in 0.1 M potassium phos- 
phate, pH 7.5, containing 0.5 mM MgClz at 25°C. The fluorescence was 
measured at 530 nm upon excitation at 465 nm after 5 min incubation at 
25°C. The fluorescence increase for tubulin was considered as 100%. 
Proteins Fluorescence 
enhancement 
% 
Tubulin 1 00 
Isocitrate dehydrogenase 83 
Alcohol dehydrogenase 80 
Glyceraldehyde-3-phosphate dehydrogenase 72 
Malate dehydrogenase 50 
Glutamate dehydrogenase 50 
Although the specificities of the interaction of colchicine and 
colcemid with tubulin are compared with that of the enzyme- 
substrate interaction, it was reported that colchicine and col- 
cemid bind glyceraldehyde-3-phosphate dehydrogenase with Kd 
values of M and 6X10-'M [18], respectively. Thus, it 
would be interesting to see whether dehydrogenases possess the 
general property of binding colchicine and its analogs. Table 1 
shows that the enhancements of NBD-colcemid fluorescence 
with different dehydrogenases decrease in the following order: 
porcine heart isocitrate dehydrogenase = LADH > yeast 
glyceraldehyde-3-phosphate dehydrogenase > porcine heart ma- 
late dehydrogenase = bovine liver glutamate dehydrogenase. 
DISCUSSION 
The pharmacological importance of colchicine is mainly due 
to its unique property of arresting eukaryotic cell division. Col- 
chicine and its analogs exert this unique effect upon binding to 
the major microtubular protein, tubulin. Besides cell division, 
there are other cellular functions such as secretion of hormones, 
axoplasmic transport, maintainance of cell shape, and cellular 
motility that are affected by colchicine at very low concentra- 
tions. Moreover, it has not been proved unequivocally that all 
these effects of colchicine are exerted through binding to tu- 
bulin. There is a report where colchicine and colcemid are 
shown to bind to yeast glyceraldehyde-3-phosphate dehydroge- 
nase [19]. 
In the present study, we show that a biologically active struc- 
tural analog of colchicine, NBD-colcemid, binds to horse liver 
alcohol dehydrogenase with high affinity. The interaction of 
LADH with NBD-colcemid enhances the intrinsic fluorescence 
of the drug and has been used for the determination of binding 
parameters. The stoichiometry of 0.62 for the binding of NBD- 
colcemid to LADH might indicate that one molecule of the drug 
bindddimer LADH. Unlike tubulin, the incubation of colchicine 
with LADH does not show any drug fluorescence. However, 
both colchicine and colcemid bind LADH and inhibit enzymic 
activity. The preincubation of LADH with colcemid decreases 
the extent of enhanced fluorescence. It is possible that this in- 
teraction does not lead to a fluorescent complex like that ob- 
served in the case of the interaction of colchicine with its anti- 
body (201. The K ,  values for colcemid and NBD-colcemid are 
100 pM and 32 pM, respectively, indicating that the substitution 
of the NBD group in the side chain of colcemid enhances its 
affinity for the enzyme about three times. The NBD group has 
considerable hydrophobic character and may provide excess 
binding energy through hydrophobic interactions, thus strength- 
ening the binding. The covalently linked NBD group may also 
result in energetically favorable entropy contributions (like a 
chelate effect) towards binding, compared to the colchicine nu- 
cleus alone. NBD-colcemid also participates in energy transfer 
with the two tryptophans of LADH. 
Finally, the binding of NBD-colcemid with several dehydrci- 
genases appears to be very interesting. A common structural ele- 
ment among dehydrogenases is the Rossmann fold, which binds 
NAD [21]. However, NAD does not compete with the NBD- 
colcemid binding indicating that the drug-binding site is dif- 
ferent from the coenzyme-binding site. The common structural 
element(s) that exists among tubulin and dehydrogenases and 
which accounts for their colchicine-binding and analog-binding 
activities remains to be established. 
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